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Abstract
Luteinizing hormone (LH) induces maturational processes in oocyte–cumulus cell complexes (OCC) of preovulatory follicles that
include both resumption of meiosis in the oocyte and expansion (mucification) of the cumulus oophorus. Both processes require activation
of mitogen-activated protein kinase (MAPK) in granulosa cells. Here, it is reported that inhibition of MAPK activation prevented
gonadotropin-stimulated resumption of meiosis as well as the rise in expression of two genes whose products are necessary for normal
cumulus expansion, Has2 and Ptgs2. However, inhibition of MAPK did not block gonadotropin-induced elevation of granulosa cell cAMP,
indicating that the activation of MAPK required for inducing GVB and cumulus expansion is downstream of cAMP. Moreover, activation
of MAPK in cumulus cells requires one or more paracrine factors from the oocyte to induce GVB and cumulus expansion; MAPK activation
alone is not sufficient to initiate these maturational processes. This study demonstrates a remarkable interaction between the oocyte and
cumulus cells that is essential for gonadotropin-induced maturational processes in OCC. By enabling gonadotropin-dependent MAPK
activation in granulosa cells, oocytes promote the generation of a return signal from these cells that induces the resumption of meiosis. It
also appears that an oocyte-dependent pathway downstream from oocyte-enabled activation of MAPK, and distinct from that promoting the
resumption of meiosis, governs cumulus expansion.
© 2003 Elsevier Inc. All rights reserved.
Introduction
In each estrous cycle of a female mammal, after the surge
of luteinizing hormone (LH), a series of well-coordinated
physiological events must occur in a preovulatory follicle to
enable the production of a fertilizable egg and ovulation.
These processes take place in both the germ cell and so-
matic cell compartments of the follicle. In the oocyte, mei-
otic maturation is a crucial process in which meiosis is
reinitiated and progresses to metaphase II, usually before
ovulation. The most obvious morphological manifestation
of the resumption of meiosis is the disappearance of the
oocyte nucleus, or germinal vesicle (GV), a process known
as germinal vesicle breakdown (GVB). Concurrent with
meiotic maturation in vivo, a dramatic maturational change
also occurs in the somatic cell compartment, in the cumulus
oophorus, the specialized subpopulation of granulosa cells
intimately associated with the oocyte. This change is cumu-
lus expansion, or mucification, which requires gonadotro-
pin-dependent increased expression of several key genes in
cumulus cells, including Has2, Ptgs2 (also known as Cox2),
Ptx3, and Tnfaip6 (Elvin et al., 1999; Fulop et al., 2003;
Joyce et al., 2001; Lim et al., 1997; Ochsner et al., 2003;
Varani et al., 2002). Cumulus expansion is required for
normal ovulation rates (Chen et al., 1993; Hess et al., 1999).
LH initiates the maturation of the oocyte–cumulus cell
complex in vivo and in cultured isolated intact ovarian
follicles. The details of the signal transduction pathways
connecting LH stimulation and the maturational processes
are not yet resolved but, various studies suggest that LH
promotes an increase in cyclic adenosine monophosphate
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(cAMP) levels within the granulosa cell compartment and a
decrease in cAMP in the oocyte, thus inducing the resump-
tion of meiosis as well as cumulus expansion (Downs and
Hunzicker-Dunn, 1995; Tsafriri et al., 1996). Differences in
expression and regulation of phosphodiesterase isoforms
expressed in the two follicular compartments are likely key
to the differential effects of LH on cAMP levels and to
understanding the mechanisms governing the resumption of
meiosis (Conti, 2002; Richard et al., 2001).
In addition to cAMP, the mitogen-activated protein ki-
nase (MAPK), specifically ERK1/2, pathway is also impor-
tant for the maturation of the oocyte–cumulus cell complex.
In oocytes, MAPK is activated indirectly by MOS (a MAPK
kinase kinase, MAPKKK), whereas in granulosa cells, it is
activated indirectly by RAS/RAF (another MAPKKK) sig-
naling. MOS is exclusively expressed in germ cells. In both
oocytes and granulosa cells, the activation of MAPK is
directly mediated by MEK (a MAPK kinase, MAPKK)
(Seger and Krebs, 1995). To study the role of MAPK in the
regulation of maturational processes in both oocytes and
cumulus cells, an in vitro model using isolated oocyte–
cumulus cell complexes has generally been utilized. In this
model, hypoxanthine, a purine found in follicular fluid
(Downs et al., 1989; Eppig et al., 1985), is used to prevent
spontaneous maturation, while the resumption of meiosis
and cumulus expansion is induced by treatment with folli-
cle-stimulating hormone (FSH) or 8Br-cAMP (Dekel and
Kraicer, 1978; Downs et al., 1988; Downs and Hunzicker-
Dunn, 1995; Eppig, 1979, 1989). Studies using this model
system demonstrated that MAPK was activated in both
cumulus cells and oocytes. Moreover, specific MEK inhib-
itors blocked oocyte GVB as well as cumulus expansion
induced by either FSH or 8Br-cAMP (Leonardsen et al.,
2000; Su et al., 2001, 2002). In sum, these studies suggested
that the MAPK pathway is involved in gonadotropin-in-
duced maturation of oocyte–cumulus cell complexes. How-
ever, MAPK activation in both cumulus cells and oocytes
can be blocked by the same MEK inhibitors, making it
difficult to distinguish in which cell type the activation of
MAPK is actually required for gonadotropin-induced mat-
uration of oocyte–cumulus cell complexes. To address
this question, the role of MAPK in gonadotropin-induced
oocyte GVB and cumulus expansion was studied by using
MostmlEv/MostmlEv (Mos-null) mice. No activation of MAPK
was detected in Mos-null oocytes induced to mature with
gonadotropins either in vivo or in vitro, thus indicating that
MAPK activation in oocytes is not necessary for gonado-
tropin-induced resumption of meiosis (Su et al., 2002).
Moreover, FSH induced GVB and cumulus expansion in
Mos-null oocytes as in the control wild type oocytes, but
both GVB and cumulus expansion were blocked by the
MEK inhibitor U0126 (Su et al., 2002). Since MAPK acti-
vation occurs only in the cumulus cells of Mos-null oocyte–
cumulus cell complexes, and not in the oocyte, it was
concluded that cumulus expansion as well as gonadotropin-
induced GVB require MAPK activation in the cumulus cells
(Su et al., 2002).
The experimental model using isolated oocyte–cumulus
cell complexes cultured in medium containing hypoxan-
thine can mimic, at least in part, the effects of LH on
maturation of both the oocyte and cumulus cell compart-
ments in intact follicles. Nevertheless, this model has some
disparities from LH-induced maturation in intact follicles.
First, FSH, rather than LH, stimulation is required to induce
GVB and cumulus expansion, since mouse cumulus cells do
not express LH-receptors (Eppig et al., 1997). Second, the
time course of GVB is delayed compared with that of
LH-induced GVB in vivo. Therefore, the question of
whether LH-induced oocyte GVB and cumulus expansion
utilizes MAPK-dependent pathways was addressed in the
present study in cultured intact antral follicles. Additionally,
the potential requirement for MAPK-dependent transcrip-
tion of two genes, Has2 and Ptgs2, necessary for normal
cumulus expansion was evaluated.
Since oocytes and granulosa cells communicate with
each other via both paracrine signals and gap junctions
(Eppig, 2001), whether MAPK activity in granulosa cells is
influenced by the oocyte was also determined. A proposed
oocyte–granulosa cell regulatory loop is driven by signals
from oocytes and granulosa cells that affect the develop-
ment and function of both cell types and are required to
coordinate follicular development (see Eppig, 2001; Matzuk
et al., 2002 for reviews). In mouse preovulatory follicles,
cumulus expansion requires the participation of a cumulus
expansion-enabling factor (CEEF) secreted by the oocyte
(Buccione et al., 1990). An oocyte-specific member of the
TGF- superfamily, growth differentiation factor-9
(GDF-9) also promotes cumulus expansion, suggesting that
GDF-9 is the CEEF (Elvin et al., 1999). However, recom-
binant GDF-9 exhibits some characteristics apparently dif-
ferent from native CEEF (Eppig, 2001; Su et al., 2002) and
raises the question whether CEEF, GDF-9, or both, can
regulate the activity of MAPK in cumulus cells. Since
MAPK activation in cumulus cells is required for the mat-
uration of both the oocyte and the cumulus oophorus, and if
factors from the oocyte are required for activation of MAPK
in the cumulus cells, we hypothesize that the oocyte plays a
central role in both maturational processes, including con-
trol of its own meiotic maturation. We employed two model
systems—isolated cumulus cell-enclosed oocytes and intact
follicles—to test this hypothesis.
Materials and methods
Follicle, cumulus cell, and oocyte isolation and culture
Immature 22-to 24-day-old (C57BL/6J SJL/J) F1 mice
were raised in the research colony of the investigators at
The Jackson Laboratory. Follicle development was stimu-
lated by ip injection with 5 IU (equine chorionic gonado-
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tropin (eCG; National Hormone and Peptide Program,
NIDDK) 44–48 h before harvesting follicles. The culture
medium used for all experiments was bicarbonate-buffered
Minimum Essential Medium  (Life Technologies, Inc.,
Grand Island, NY) with Earle’s salts, supplemented with 75
mg/liter penicillin G, 50 mg/liter streptomycin sulfate, 0.23
mM pyruvate, and 3 mg/ml crystallized lyophilized bovine
serum albumin. All media components were purchased
from Sigma (St. Louis, MO).
Large antral follicles were isolated in medium supple-
mented with 10% fetal bovine serum as described previ-
ously (Dekel and Sherizly, 1985; Tsafriri et al., 1972). After
three washes in medium, the follicles were cultured on
collagen-coated membranes as described previously (Eppig
and O’Brien, 1996). Each culture well contained approxi-
mately 1.5 ml of medium beneath the membrane insert and
only a thin film of medium covering the follicles. Follicle
culture was carried out at 37°C in a modular incubation
chamber (Billups Rothenberg, Del Mar, CA) infused with
5% CO2 and 95% air. During culture, follicles were treated
with 10 g/ml of ovine LH (National Hormone and Pitu-
itary Program, NIDDK) or LH plus various doses of the
highly specific MEK1/2 inhibitor U0126 or its inactive
analog U0124 (Favata et al., 1998) (Calbiochem, La Jolla,
CA).
To isolate cumulus cell-enclosed oocytes, large antral
follicles on the surface of ovaries were punctured with
26-gauge needles. Cumulus cells and denuded oocytes were
obtained by drawing the oocyte–cumulus cell complexes
(OCCs) into and out of a small-bore pipette, gently shearing
off the cumulus cells. Culture of OCCs, cumulus cells, or
cumulus cells cocultured with denuded oocytes was carried
out in 30 l drops of medium under washed paraffin oil at
37°C in a modular incubation chamber infused with 5% O2,
5% CO2, and 90% N2. During culture, the cells were treated
with FSH (National Hormone and Pituitary Program,
NIDDK), recombinant GDF-9 (generously provided by Dr.
Martin M. Matzuk at Baylor College of Medicine, Houston,
TX), the MEK inhibitor U0126, or its inactive analog
U0124.
Activation of MAPK
MAPK activity in cumulus cells was determined indi-
rectly by detection of phosphorylated (active) forms of
MAPK using Western blot analysis as described previously
(Su et al., 2002). Phosphorylated MAPK was detected by
using a monoclonal anti-diphosphorylated ERK1 and-2 an-
tibody (Sigma). The second antibody was horseradish per-
oxidase-conjugated goat anti-mouse IgG (Jackson Im-
munoResearch Laboratories, Inc., West Grove, PA). The
total amount of MAPK (phosphorylated and unphosphory-
lated forms) on the same membrane was assayed by using a
polyclonal anti-MAPK antibody (Sigma) after stripping off
the initial bound antibodies. In this reaction, horseradish
peroxidase-conjugated donkey anti-rabbit IgG (Jackson Im-
munoResearch Laboratories, Inc.) was used as the second-
ary antibody.
Measurement of cAMP levels
The levels of cAMP in OCCs were measured by using
the cAMP-125I-Direct Biotrak Assay by Amersham Sci-
ences (Piscataway, NJ). OCCs were incubated in control
medium or in medium with FSH (100 IU/liter) or FSH plus
U0126 or U0124 (10 M). All groups were cultured in
medium supplemented with 50 M isobutyl methylxan-
thine. Complexes were cultured for 3 h before cells were
lysed and cAMP assayed. The experiment was conducted
three times with the samples in each group analyzed in
triplicate.
Evaluation of oocyte GVB and cumulus expansion
Oocyte GVB were scored at 4 h after intact follicle
culture. OCCs were released by puncturing the follicles with
a 26-gauge needle, and GVB was evaluated under a ste-
reomicroscope after the cumulus cells were stripped off
with a small-bore glass pipette. Cumulus expansion was
evaluated after 12 h of intact follicle culture by histological
assessment. Follicles were fixed in Bouin’s fixing solution
overnight, then washed, dehydrated, and embedded in par-
affin wax. Sections were cut at 4-m thickness and stained
with periodic acid/Schiff reagent and hematoxylin.
Comparison of Has2 and Ptgs2 mRNA steady state levels
The steady-state expression by cumulus cells of Has2
and Ptgs2 mRNA was determined by RNase protection
assay as described previously (Eppig et al., 1998; Joyce et
al., 2001). The Has2 RNA probe was generated from a
mouse Has2 cDNA provided by Dr. Martin M. Matzuk. The
Ptgs2 RNA probe was generated from a mouse Ptgs2 cDNA
provided by Dr. S.K. Dey (Vanderbilt University School of
Medicine). Antisense Has2 and Ptgs2 probes were labeled
with [-32P]CTP (NEN Life Science Products, Boston,
MA), using MAXI script kits (Ambion, Inc., Austin, TX). A
[-32P]CTP-labeled antisense Rpl19 RNA probe was in-
cluded in each sample to allow differences in the quantity of
mRNA between samples to be corrected mathematically
(Eppig et al., 1998). After electrophoresis, band intensity
was quantified by using a phosphor imaging system (Fuji
Photo Film Co., Ltd., Stamford, CT) and standardized to
account for variable mRNA levels per sample.
Statistical analysis
Experiments were repeated independently a minimum of
three times. The number of experimental replicates is indi-
cated in the figure legends. Data were statistically compared
by ANOVA using StatView software (SAS Institute, Inc.,
Cary, NC). When a significant F ratio was defined by
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ANOVA, groups were compared by using Fisher’s pro-
tected least significant difference post hoc test. P  0.05
was considered significant. In the oocyte maturation exper-
iments, 30–35 follicles or OCCs were utilized in each
experiment. The data are reported as the mean percentage of
GVB  SEM. All frequencies were subjected to arcsin
transformation before analysis.
Results
Effect of MEK inhibitor on LH-induced oocyte GVB and
cumulus expansion in intact large antral follicles in vitro
The hypothesis that a MAPK-dependent pathway partic-
ipates in LH-induced oocyte GVB and cumulus expansion
in intact follicles was tested. Large antral follicles were
initially treated with various doses of U0126 [a specific
MEK1/2 inhibitor (Favata et al., 1998)] or U0124 (an inac-
tive analog of U0126) for 1 h, LH was then added to the
medium at a final concentration of 10 g/ml. After 4 h of
culture, the majority of the oocytes isolated from the large
antral follicles in the control group without LH or MEK
inhibitor treatments were maintained at the GV stage, with
a GVB rate of less than 20% (Fig. 1). In contrast, when
follicles were treated with 10 g/ml of LH alone, almost all
the oocytes in these follicles underwent GVB. The stimu-
latory effect of LH on GVB in follicle-enclosed oocytes
was, however, dose-dependently inhibited by U0126; 10
M U0126 was effective to inhibit LH-induced GVB, and
100 M U0126 almost totally blocked the effect of LH on
GVB rate. At the same concentration, U0124, the inactive
analog of the MEK inhibitor U0126, had no inhibitory effect
on LH-induced GVB. Although there was a significant
inhibition of LH-induced GVB at a concentration of 50 M
U0126, a high concentration (100 M), which could pro-
duce nonspecific effects, was required to produce maximum
inhibition. However, it is impossible to know the concen-
tration of inhibitor deep within the cultured intact follicles.
Indeed, a high concentration of 50 M U0126 was found to
be efficient to inactivate MAPK and induce mouse egg
parthenogenetic activation (Phillips et al., 2002). These re-
sults with LH-treated intact follicles, strongly support the
hypothesis that gonadotropin-induced resumption of meio-
sis requires somatic cell activation of MAPK. In addition,
this helps to validate the physiological significance of FSH-
induced MAPK activation and GVB in the isolated cumulus
cell-enclosed model system.
Cumulus expansion was evaluated in intact follicles cul-
tured for 12 h. No expansion was observed in the control
group follicles; the intact cumulus layers remained in close
contact with GV-stage oocytes (Fig. 2A). Conversely, in the
group treated with 10 g/ml LH, cumulus cells underwent
full expansion and their tight association with the oocyte
was lost. Both the mature oocyte and cumulus cells became
separated from the follicle wall (Fig. 2B). LH-induced cu-
mulus expansion was completely blocked by 100 M
U0126 (Fig. 2C), but not by the same dose of U0124 (Fig.
2D).
In summary, in follicles treated with U0126 plus LH, the
oocyte was maintained at GV-stage, and the intact cumulus
layers remained tightly associated with both the oocyte and
the follicle wall. By contrast, in follicles treated with the
inactive analog plus LH, the oocyte underwent GVB and the
cumulus underwent full expansion, exactly as in the LH-
treated follicles. Thus, LH-induced activation of follicular
MAPK was required for the maturation of both the oocyte
and cumulus oophorus.
Effect of MEK inhibitor on steady-state levels of
gonadotropin-induced Has2 and Ptgs2 mRNA expression
in cumulus cells
The observation that the MAPK-dependent pathway is
essential for both LH-induced cumulus expansion within
intact follicles (above) and FSH-induced cumulus expan-
sion of OCCs in vitro (Su et al., 2002) suggest that MAPK
participates in gonadotropin-induced expression of the
genes involved in cumulus expansion. Both Has2 and Ptgs2
are expressed in the cumulus cells, and their expression is
essential for cumulus expansion. Therefore, it was deter-
mined whether MAPK activity is required for gonadotropin-
Fig. 1. MEK inhibitor dose-dependently blocks LH-induced GVB in intact
isolated follicles. Large antral follicles isolated from eCG-primed 22-to
24-day-old mouse ovaries were cultured in vitro using approximately
30–35 follicles per well. Follicles were initially treated with 5–100 M
U0126 (solid circles) or U0124 (open circles) for 1 h; LH was then added
to the culture medium to a final concentration of 10 g/ml. The incidence
of oocyte GVB was scored after 4 h of culture. Results are presented as the
mean and standard errors of the mean of five independent experiments.
Where there are no common letters over the points, the groups were
significantly different (P  0.05). Control indicates the group with no
treatment. LH indicates the group treated only with 10 g/ml LH without
MEK inhibitor.
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induced expression of Has2 and Ptgs2 mRNA in the cumu-
lus cells.
First, to test the involvement of MAPK in LH-induced
gene expression, large antral follicles were initially treated
with 100 M U0126 or U0124 for 1 h; LH was then added
into the medium at a final concentration of 10 g/ml and
follicles were cultured for 6 h. At the end of culture, cumu-
lus cells were isolated and the steady-state levels of Has2
and Ptgs2 mRNA were determined. Very low levels of
Has2 and Ptgs2 mRNA were detected in the control group;
however, LH stimulated mRNA expression of both genes in
the cumulus cells, with 1.8-and 6-fold increase, respectively
(Fig. 3B and C). Moreover, U0126 (but not U0124) inhib-
ited LH-stimulated expression of Has2 and Ptgs2 mRNA,
Fig. 2. MEK inhibitor blocks LH-induced cumulus expansion in mouse preovulatory follicles. Large antral follicles were cultured for 12 h. At the end of
culture, follicles were fixed and sectioned for histological analysis. (A) Control follicle. (B) Follicle treated with 10 g/ml LH; note the expanded cumulus
oophorus. (C) Follicle treated with 100 M U0126 plus 10 g/ml LH. The MEK inhibitor blocked both cumulus expansion and GVB, note intact GV (arrow).
(D) Follicle treated with 100 M U0124 plus 10 g/ml LH. The inactive analog of the MEK inhibitor (U0124) did not prevent LH-induced cumulus
expansion or oocyte maturation. Scale bar, 100 m.
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resulting in the same levels of expression as in control
groups.
Second, to test the involvement of a MAPK-dependent
pathway in the regulation of steady state expression of Has2
and Ptgs2 mRNA in cumulus cells stimulated by FSH,
isolated OCCs were initially treated with 10 M of U0126
or U0124 for 30 min before FSH was added to the culture
medium at a final concentration of 100 IU/liter. After a 6-h
culture, cumulus cells were stripped from the oocyte and the
expression of Has2 and Ptgs2 in the cumulus cells deter-
mined. Low levels of Has2 and Ptgs2 mRNA were detected
in the control group. FSH stimulated expression of both
Has2 and Ptgs2 mRNA in cumulus cells with 3.2-and 3.4-
fold increase, respectively (Fig. 4B and C); however, this
stimulatory effect was inhibited by 10 M of U0126, but
not U0124. The levels of Has2 and Ptgs2 mRNA in the
group treated with U0126FSH were the same as that in
control group without FSH, while the levels in the group
treated with U0124FSH were the same as that in the group
treated with FSH.
Requirement of MAPK activity for elevation of Has2 and
Ptgs2 steady-state mRNA expression in FSH-stimulated
cumulus cells cocultured with oocytes and in cumulus
cells treated with GDF-9
It was previously shown that both the oocyte and GDF-9
promote cumulus expansion as well as Has2 and Ptgs2
Fig. 3. MEK inhibitor blocks LH-induced Has2 and Ptgs2 mRNA expres-
sion in cumulus cells of preovulatory follicles. Large antral follicles were
cultured for 6 h with no treatment (control), 10 g/ml LH (LH), 10 g/ml
LH plus 100 M U0126 (LHU0126), or 10 g/ml LH plus 100 M
U0124 (LHU0124). At the end of culture, the cumulus cells were isolated
and the steady state levels of Rpl19, Has2, and Ptgs2 mRNA assessed by
RNase protection assay. Has2 and Ptgs2 mRNA values were first corrected
to Rpl19 values to adjust for differences in loading between samples. Then,
for each experiment, the control values were arbitrarily set at 1 and
experimental groups were calculated relative to this value to allow unbi-
ased comparisons of groups among experiments. All the RNase protection
data shown in subsequent figures are presented in this manner. (A) A
representative phosphorimage (Fuji Photo Film Co., Ltd.) of Rpl19, Has2,
and Ptgs2 mRNA. (B) Normalized steady-state levels of Has2 mRNA in
cumulus cells. (C) Normalized steady-sate levels of Ptgs2 mRNA in
cumulus cells. The values shown are the mean (SEM) values from four
experimental replicates. Where there are no common letters over the bars,
the groups were significantly different (P  0.05).
Fig. 4. MEK inhibitor blocks FSH-induced Has2 and Ptgs2 mRNA ex-
pression in the cumulus cells of isolated OCCs. OCCs were cultured for 6 h
with no treatment (control), with 100 units/liter FSH (FSH), 100 units/liter
FSH plus 10 M U0126 (FSHU0126), or 100 units/liter FSH plus 10 M
U0124 (FSHU0124). At the end of the culture, cumulus cells were
isolated and the steady state levels of Rpl19, Has2, and Ptgs2 mRNA
assessed as described in the legend to Fig. 3. (A) Normalized levels Has2
mRNA in cumulus cells. (B) Normalized levels of Ptgs2 mRNA in cumu-
lus cells. The values shown are the mean (SEM) values of three inde-
pendent experiments. Where there are no common letters over the bars, the
groups were significantly different (P  0.05).
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expression in the cumulus cells (Buccione et al., 1990; Elvin
et al., 1999, 2000; Joyce et al., 2001; Su et al., 2002; Tirone
et al., 1997, 1993). Moreover, the MEK inhibitor is known
to block GDF-9-induced cumulus expansion (Su et al.,
2002). Therefore, it is possible that the oocyte and/or
GDF-9 might regulate the MAPK-dependent cumulus ex-
pansion process. The following experiments tested this hy-
pothesis. Isolated cumulus cells either were cocultured with
the fully grown GV-stage oocytes at a density of 2 oo-
cytes/l and treated with 100 IU/liter FSH plus 10 M
U0126 or U0124; or were cultured alone and treated with
100 ng/ml of GDF-9 plus 10 M U0126 or U0124. After 6 h
of culture, cumulus cells were collected and their steady-
state levels of Has2 and Ptgs2 mRNA were determined. In
the control group, where isolated cumulus cells were treated
with FSH alone, low level of Has2 mRNA and almost no
Ptgs2 mRNA were detected (Fig. 5). When oocytes were
added to the culture, relatively high levels of both Has2 and
Ptgs2 mRNA were detected in the cumulus cells. However,
treatment with 10 M U0126, but not U0124, almost totally
blocked these increases in the steady state levels of Has2
and Ptgs2 mRNA. Similarly, recombinant GDF-9, in the
absence of FSH, elevated the expression of both Has2 and
Ptgs2 in isolated cumulus cells. The stimulatory effect of
GDF-9 was completely blocked by U0126, but not U0124
(Fig. 6). Therefore, elevation of the steady-state levels of
Has2 and Ptgs2 mRNA requires activation of MAPK by the
oocyte with FSH, or by GDF-9 without FSH.
Effect of oocytes on FSH-induced activation of MAPK in
cumulus cells
Observations that the MEK inhibitor blocked oocyte plus
FSH induced Has-2 and Ptgs2 mRNA expression in the
cumulus cells suggest that the oocyte may also participate in
the regulation of MAPK activity in the cumulus cells. This
hypothesis was tested, by comparing MAPK activity in
response to FSH by the cumulus cells of OCCs relative to
isolated cumulus cells. We found that FSH promotes the
activation of MAPK in cumulus cells of intact OCCs within
30 min (Fig. 7), but there was little activation of MAPK in
cumulus cells in the absence of the oocyte. Moreover, co-
culture of cumulus cells with denuded oocytes (4–5 fully
grown GV-stage oocytes/l) maintains the ability of FSH to
promote MAPK activation (Fig. 7). These data indicate that
a paracrine factor produced by oocytes enables cumulus
cells to activate MAPK in response to gonadotropic stimu-
lation.
The ability of oocytes to enable isolated cumulus cells to
respond to FSH with stimulation of MAPK activation is
dependent on the density of the oocytes cocultured with the
cumulus cells (Fig. 8A). When isolated cumulus cells were
cocultured with oocytes at a density of 1.5 oocytes/l of
culture medium, MAPK activity in FSH-treated isolated
cumulus cells began to increase, and the highest levels of
MAPK activity in the cumulus cells were detected when
they were cocultured with oocytes at a density of 2–4
oocytes/l of culture medium.
To assess whether the ability of oocytes to enable acti-
vation of MAPK in response to FSH depends on the devel-
opmental stage of the oocytes, cumulus cells were cocul-
tured with partly grown GV-stage oocytes isolated from
preantral follicles of 12-day-old mice, with fully grown,
meiotically competent GV-stage oocytes from 22-day-old
mice, or with metaphase II oocytes isolated from the ovi-
ducts of superovulated 22-day-old mice. Oocytes at all
stages tested enabled FSH-induced activation of MAPK in
cumulus cells (Fig. 8B).
Fig. 5. MEK inhibitor blocks oocyte-enabled Has2 and Ptgs2 mRNA
expression in isolated cumulus cells treated with FSH. Isolated mouse
cumulus cells were either cultured alone and treated with 100 units/liter
FSH (FSH) for 6 h or cocultured with fully grown oocytes, at a density of
2 oocytes/l, and treated with 100 units/liter FSH (FSHOocyte), 100
units/liter FSH plus 10 M U0126 (FSHU0126Oocyte), or 100 units/
liter FSH plus 10 M U0124 (FSHU0124Oocyte) for 6 h. At the end
of the culture, cumulus cells were isolated and the steady state levels of
Rpl19, Has2, and Ptgs2 mRNA assessed as described in the legend to Fig.
3. (A) Normalized levels of Has2 mRNA in cumulus cells. (B) Normalized
levels of Ptgs2 mRNA in cumulus cells. The values shown are the mean
(SEM) values of four independent experiments. Where there are no
common letters over the bars, the groups were significantly different (P 
0.05).
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Effect of GDF-9 on activation of MAPK in cumulus cells
GDF-9, an oocyte-specific member of the TGF super-
family (McGrath et al., 1995), is thought to mediate several
of the effects of oocytes on granulosa cell differentiation
and function, including cumulus expansion (Eppig, 2001;
Matzuk et al., 2002). We assessed the effects of recombi-
nant GDF-9 on activation of MAPK in cumulus cells.
GDF-9 stimulated the activation of MAPK in the absence of
FSH (Fig. 8C). When isolated cumulus cells were treated
with GDF-9, a dose-dependent effect on MAPK activity
was observed (Fig. 8C). An increase in MAPK activity was
observed when the cumulus cells were treated with 5 ng/ml
GDF-9, and the highest levels of MAPK activity were
detected when the cumulus cells were treated with 20–100
ng/ml GDF-9.
Effect of recombinant GDF-9 on the resumption of
meiosis by cumulus cell-enclosed oocytes
Since GDF-9 induced MAPK activation in cumulus
cells, the ability of GDF-9 to induce the resumption of
meiosis was determined. Cumulus cell-enclosed oocytes
were maintained in meiotic arrest by hypoxanthine (all
groups) and treated with GDF-9, together with FSH, or with
GDF-9 plus FSH. There were two control groups of cumu-
lus cell-enclosed oocytes not treated with either GDF-9 or
FSH: one group maintained in the standard culture medium
used throughout this study and the other in medium con-
taining the same proportion of conditioned medium as the
recombinant GDF-9-treated group, but conditioned by un-
transfected cells. GDF-9 did not stimulate the resumption of
meiosis, nor did it increase the frequency of GVB induced
by FSH (Fig. 9).
Inhibition of MAPK activation does not prevent FSH-
induced elevation of cAMP levels in cumulus cells
Previous studies showed that the membrane permeable
analog of cAMP, 8Br-cAMP, induced GVB and that the
MEK1/2 inhibitor U0126 blocked this effect of cAMP on
oocyte maturation (Su et al., 2002). These results suggest
that GVB is promoted by elevation of cAMP in the cumulus
cells and that the effect of cAMP is mediated by activation
Fig. 6. MEK inhibitor blocks GDF-9-induced Has2 and Ptgs2 mRNA
expression in isolated cumulus cells. Isolated cumulus cells were cultured
for 6 h in control medium or medium supplemented with 100 ng/ml GDF-9
(GDF-9), 100 ng/ml GDF-9 plus 10 M U0126 (GDF-9U0126), or 100
ng/ml GDF-9 plus 10 M U0124 (GDF-9U0124). At the end of the
culture, cumulus cells were collected and the steady-state levels of Rpl19,
Has2, and Ptgs2 mRNA assessed as described in the legend to Fig. 3. (A)
Normalized levels Has2 mRNA in cumulus cells. (B) Normalized levels of
Ptgs2 mRNA in cumulus cells. The values shown are the mean (SEM)
values of three independent experiments. Where there are no common
letters over the bars, the groups were significantly different (P  0.05).
Fig. 7. Activation of MAPK in cumulus cells: effects of FSH, oocytes, and
recombinant GDF-9. Mouse OCCs or isolated cumulus cells were treated
with FSH or GDF-9 respectively, and cultured for 1–4 h in vitro. In
addition, cumulus cells from 30 OCCs were collected immediately at the
beginning of the culture to work as the 0-h control. At the end of culture,
cumulus cells were collected and MAPK activity was assessed indirectly
by western blot analysis using a specific anti-active MAPK monoclonal
antibody (indicated in the top panels). The total amounts of MAPK protein
(indicated in the bottom panels) were determined by reprobing the same
blot using an anti-MAPK polyclonal antibody. Cumulus cells from 30
OCCs were loaded into each lane. The positions of the two MAPK
isoforms (ERK1 and-2) are indicated on the left of each gel. The experi-
ment was repeated three times with similar results, and a representative gel
is shown. CC/OCC, cumulus cells of OCCs. CC/OOX, isolated cumulus
cells. OCoC, isolated cumulus cells cocultured with denuded oocytes (4
oocytes/l of medium) isolated from 22-day-old mice.
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of MAPK. However, it remained possible that inhibition of
MAPK activity prevents FSH-induced elevation of cAMP
levels in cumulus cells and that FSH induces GVB by a
cAMP-independent pathway. However, U0126 had no ef-
fect on elevation of cAMP levels in cumulus cells stimu-
lated by FSH (Fig. 10), supporting the hypothesis that the
pathway for gonadotropin-induced resumption of meiosis is
mediated sequentially by cAMP then MAPK.
Discussion
A preovulatory surge of LH stimulates the maturation of
the oocyte–cumulus cell complex, processes that include
both the resumption of meiosis in the oocyte and the mu-
cification and expansion of the cumulus oophorus. How-
ever, neither of these processes took place in intact follicles
cultured with LH and a highly specific MEK1/2 inhibitor
that blocks the activation of MAPK. Therefore, since acti-
vation of MAPK in mammalian oocytes is not required for
the resumption of meiosis (GVB) (Araki et al., 1996; Phil-
lips et al., 2002; Su et al., 2001, 2002; Verlhac et al., 1996),
LH-induced GVB requires the activation of MAPK in the
somatic cell compartment of the follicle. Moreover, al-
though it was previously shown that activation of MAPK is
required for cumulus expansion (Su et al., 2002), the present
experiments demonstrate that MAPK activation is required
for the transcription of two genes (Has2 and Ptgs2) essential
for cumulus expansion. This does not exclude the possibil-
ity that posttranscriptional processes are also affected.
It was previously known that expansion of the mouse
cumulus oophorus requires a factor secreted by the oocyte,
the cumulus expansion enabling factor (CEEF) (Buccione et
al., 1990), and that FSH-stimulated cumulus expansion in
vitro requires activation of MAPK in the cumulus cells of
isolated OCCs (Su et al., 2002). However, it was not known
whether oocytes are required for gonadotropin-dependent
activation of MAPK in the cumulus cells or whether this
activation is upstream of the oocyte-dependent pathway
required for cumulus expansion. Here, we show that de-
nuded oocytes cocultured with isolated cumulus cells
greatly enhanced MAPK activity in cumulus cells stimu-
lated by FSH, while MAPK activity was low in the absence
of oocytes. This indicates that oocytes secrete one or more
paracrine factors needed to promote MAPK activity in cu-
mulus cells. Moreover, since elevated MAPK activity in
cumulus cells is required for the maturation of both the
oocyte and the cumulus oophorus, the oocyte itself thus
Fig. 8. Oocytes and GDF-9 promote the activation of MAPK in isolated
cumulus cells. (A) Isolated mouse cumulus cells were cocultured with fully
grown oocytes isolated from 22-day-old mice at a density of 0–4 oo-
cyte(s)/l and treated with FSH for 4 h. (B) Isolated cumulus cells stim-
ulated with FSH and cocultured with partly grown oocytes (PGO) (10
oocytes/l) isolated from the preantral follicles of 12-day-old mice, fully
grown oocytes (FGO) (5 oocytes/l), and metaphase II oocytes (MII) (5
oocytes/l). (C) Isolated cumulus cells were treated with various doses of
GDF-9 (0–100 ng/ml) and cultured for 4 h. The experiment was repeated
three times with similar results, and a representative gel is shown.
Fig. 9. FSH, but not GDF-9, stimulates the resumption of meiosis (GVB)
in hypoxanthine-treated OCCs. OCCs were cultured in medium containing
4 mM hypoxanthine. Control-1 (C-1) was the standard Minimum Essential
Medium , and Control-2 (C-2) included the same proportion of condi-
tioned medium as in the GDF-9-treated group, but conditioned by untrans-
fected cells. GVB was assessed after 15 h of culture. Results are presented
as the mean and standard errors of the mean of three independent exper-
iments, and approximately 40 OCC were included in each group in each
experiment. Where there are no common letters over the bars, the groups
were significantly different (P  0.05).
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plays a key role in enabling, or licensing, both of these
maturational processes.
Gonadotropin-dependent activation of MAPK is down-
stream of elevation of granulosa cell cAMP levels and the
activation of PKA (Cameron et al., 1996; Das et al., 1996;
Seger et al., 2001). In the cumulus cells, the membrane
permeable cAMP analog, 8Br-cAMP, stimulates activation
of MAPK. Moreover, inhibition of MAPK activity blocked
both 8-Br-cAMP-induced oocyte GVB and cumulus expan-
sion (Su et al., 2002). Thus, the cAMP-PKA pathway reg-
ulates these functions of cumulus cells by activation of
MAPK, although the relationship of the PKA and MAPK
pathways is not understood. FSH-dependent elevation of
cumulus cell cAMP levels is independent of oocyte para-
crine factors arid cumulus cell MAPK activation since FSH
induces cAMP production to the same levels in cumulus
cells in the absence of the oocyte as in intact oocyte-
cumulus cell complexes (Buccione et al., 1990), and this
elevation of cAMP levels is not affected by the MEK1/2
inhibitor (as shown in this paper). These results also dem-
onstrated that separation of cumulus cells from oocytes and
inhibition of MAPK activity in the cumulus cells do not
affect the function of FSH receptors. Therefore, the likely
path of gonadotropin action begins with the elevation of
cAMP levels in granulosa cells promoting the activation of
MAPK followed by the events leading to GVB and cumulus
expansion. Importantly, in cumulus cells, cAMP-dependent
activation of MAPK, which is necessary for GVB and
cumulus expansion, requires the presence of one or more
factors secreted by oocytes.
Is activation of cumulus cell MAPK sufficient to launch
the specific processes leading to oocyte resumption of mei-
osis and cumulus expansion? Two lines of evidence suggest
that it is not. First, in conjunction with FSH, paracrine
factors from partly grown oocytes isolated from preantral
follicles were able to activate MAPK in cumulus cells. Yet,
cumulus expansion does not occur in this case (Vanderhy-
den et al., 1990) nor does increased Ptgs2 mRNA expres-
sion (Joyce et al., 2001). Second, recombinant GDF-9 pro-
motes the activation of MAPK in cumulus cells (Su et al.,
2002, and this study). Yet GDF-9, alone or in combination
with FSH, does not promote GVB (in the presence of
hypoxanthine). Nevertheless, recombinant GDF-9 promotes
Has2 and Ptgs2 expression and cumulus expansion in the
absence of FSH, and this stimulation required MAPK acti-
vation (Elvin et al., 1999; Su et al., 2002, and this study).
Thus, activation of MAPK in cumulus cells is necessary but
not sufficient for launching the pathways leading either to
the induction of GVB in oocytes or to cumulus expansion.
In fact, these maturational pathways appear distinct from
each other, and the differences may be in events down-
stream from MAPK activation (Fig. 11). However, it cannot
be excluded that there are independent, parallel pathways
leading to MAPK activation.
Partly grown oocytes isolated from preantral follicles
enabled FSH-dependent activation of MAPK in cumulus
cells, but, unlike fully grown oocytes, did not enable cumu-
lus expansion (Vanderhyden et al., 1990) or increased Ptgs2
mRNA expression (Joyce et al., 2001). This suggests that
paracrine factors secreted by oocytes at the two stages of
development are different. The nature of this difference is
unknown. It is possible that a specific factor acting down-
stream of, or parallel to, the MAPK-activation enabling
factor is secreted only by fully grown oocytes. It also
seemed possible that partly grown oocytes might secrete a
factor that blocks the action of the cumulus expansion
enabling factor. However, in unpublished experiments,
partly grown oocytes were co-cultured with fully grown
oocytes, with the partly grown oocytes in great numerical
excess, and did not interfere with the ability of the fully
grown oocytes to enable cumulus expansion. This suggests
that partly grown oocytes do not secrete a blocking factor
that could prevent the activity of a cumulus expansion
enabling factor.
It is puzzling that recombinant GDF-9 promotes expres-
sion of Has2 and other genes required for cumulus expan-
sion and induces the MAPK activation required for cumulus
expansion, but, unlike native paracrine factors secreted by
oocytes, does not require FSH to induce cumulus expansion.
Perhaps FSH promotes cumulus cell production of a factor
that modifies the structure, and therefore regulates the func-
tion, of native GDF-9 produced by oocytes. Recombinant
GDF-9 may be produced in this modified form and therefore
not require the FSH-dependent factor produced by cumulus
cells. Resolution of this issue must await further studies.
In conclusion, this study demonstrates a remarkable in-
teraction between oocytes and their companion cumulus
cells that is essential for gonadotropin-induced maturation
of both the somatic cell and germ cell compartments of the
oocyte-cumulus cell complex (Fig. 11). In our current work-
ing model, gonadotropin induces both the resumption of
meiosis and cumulus expansion by mechanisms requiring
the activation of MAPK in the cumulus cells, but this
Fig. 10. Inhibition of MAPK activation does not prevent FSH-induced
elevation of cAMP. Complexes were incubated for 3 h before assessment
of cAMP levels by radioimmunoassay. Results are presented as the mean
and standard errors of the mean of three independent experiments. Where
there are no common letters over the bars, the groups were significantly
different (P  0.05).
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activation cannot occur in the absence of the oocyte, and is
likely mediated by one or more paracrine factors. Thus,
oocytes enable, or license, the cumulus cells to produce, in
response to gonadotropin-induced elevation of granulosa
cell cAMP, a return signal that induces the resumption of
meiosis. It also appears that an oocyte-dependent pathway
downstream from oocyte-enabled activation of MAPK, and
distinct from that promoting the resumption of meiosis,
governs cumulus expansion (Fig. 11).
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